Resultados da busca - Gee‐Chen Chang

Refinar Resultados
  1. 1
    Genetic Polymorphism of XRCC1 Arg399Gln Is Associated With Survival in Non–Small-Cell Lung Cancer Patients Treated With Gemcitabine/Platinum

    Genetic Polymorphism of XRCC1 Arg399Gln Is Associated With Survival in Non–Small-Cell Lung Cancer Patients Treated With Gemcitabine/Platinum por Wei‐Yu Liao, Jin‐Yuan Shih, Gee‐Chen Chang, Yu-Kai Cheng, James Chih‐Hsin Yang, Yuh‐Min Chen, Chong‐Jen Yu

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  2. 2
    Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer

    Digoxin Suppresses Tumor Malignancy through Inhibiting Multiple Src-Related Signaling Pathways in Non-Small Cell Lung Cancer por Sheng-Yi Lin, Hsiu-Hui Chang, Yi-Hua Lai, Ching‐Hsiung Lin, Min-Hsuan Chen, Gee‐Chen Chang, Meng-Feng Tsai, Jeremy J.W. Chen

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy

    Curcumin Induces EGFR Degradation in Lung Adenocarcinoma and Modulates p38 Activation in Intestine: The Versatile Adjuvant for Gefitinib Therapy por Jen‐Yi Lee, Yee-Ming Lee, Gee‐Chen Chang, Sung‐Liang Yu, Wan-Yu Hsieh, Jeremy J.W. Chen, Huei‐Wen Chen, Pan‐Chyr Yang

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    P2.14-59 Osimertinib in EGFR T790M Advanced NSCLC: Analysis of Uncommon/Complex EGFR Mutations in a Real-World Study (ASTRIS)

    P2.14-59 Osimertinib in EGFR T790M Advanced NSCLC: Analysis of Uncommon/Complex EGFR Mutations in a Real-World Study (ASTRIS) por Parneet Cheema, Antonio Passaro, Charles E. Martin, Marcello Tiseo, K. Park, Gee‐Chen Chang, Yang Hu, Byoung Chul Cho, Margarida S. Miranda, A. Fernandes, H. Freitas

    Publicado em 2019
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer

    RAGE acts as an oncogenic role and promotes the metastasis of human lung cancer por Mei‐Chih Chen, Kun‐Chieh Chen, Gee‐Chen Chang, Ho Lin, Chun‐Chi Wu, Wei-Hsiang Kao, Chieh‐Lin Jerry Teng, Shih‐Lan Hsu, Tsung‐Ying Yang

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  6. 6
    Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects

    Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects por Yi‐Jing Hsiao, Min-Shu Hsieh, Gee‐Chen Chang, Yin-Chen Hsu, C Y Wang, Yan-Ming Chen, Yi-Ling Chen, Pan‐Chyr Yang, Sung‐Liang Yu

    Publicado em 2025
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients

    PD-L1 strong expressions affect the clinical outcomes of osimertinib in treatment naïve advanced EGFR-mutant non-small cell lung cancer patients por Kuo-Hsuan Hsu, Jeng‐Sen Tseng, Tsung‐Ying Yang, Kun‐Chieh Chen, Kang‐Yi Su, Sung‐Liang Yu, Jeremy J.W. Chen, Yen-Hsiang Huang, Gee‐Chen Chang

    Publicado em 2022
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Terpinen-4-ol Induces Apoptosis in Human Nonsmall Cell Lung Cancer In Vitro and In Vivo

    Terpinen-4-ol Induces Apoptosis in Human Nonsmall Cell Lung Cancer In Vitro and In Vivo por Chieh‐Shan Wu, Yun‐Ju Chen, Jeremy J.W. Chen, Jeng‐Jer Shieh, Chia-Hsin Huang, Pei-Shan Lin, Gee‐Chen Chang, JingHua-Tsai Chang, Chi‐Chen Lin

    Publicado em 2011
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer

    The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer por Ming‐Fang Wu, Chih-An Lin, Tzu‐Hang Yuan, Hsiang‐Yuan Yeh, Sheng‐Fang Su, Chin‐Lin Guo, Gee‐Chen Chang, Ker-Chau Li, Chao‐Chi Ho, Huei‐Wen Chen

    Publicado em 2020
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  10. 10
    The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma

    The Motor Protein KIF14 Inhibits Tumor Growth and Cancer Metastasis in Lung Adenocarcinoma por Pei-Fang Hung, Tse‐Ming Hong, Yi‐Chiung Hsu, Hsuan‐Yu Chen, Yih‐Leong Chang, Chen‐Tu Wu, Gee‐Chen Chang, Yuh‐Shan Jou, Szu‐Hua Pan, Pan‐Chyr Yang

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma

    A Randomized Phase 2 Study Comparing the Combination of Ficlatuzumab and Gefitinib with Gefitinib Alone in Asian Patients with Advanced Stage Pulmonary Adenocarcinoma por Tony Mok, Sarayut Lucien Geater, Wu‐Chou Su, Eng-Huat Tan, James Chih‐Hsin Yang, Gee‐Chen Chang, May Han, Philip Komarnitsky, Francis Payumo, Jennifer Garrus, Sandra Close, Keunchil Park

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma

    Dynamic Plasma EGFR Mutation Status as a Predictor of EGFR-TKI Efficacy in Patients with EGFR-Mutant Lung Adenocarcinoma por Jeng‐Sen Tseng, Tsung‐Ying Yang, Chi‐Ren Tsai, Kun‐Chieh Chen, Kuo-Hsuan Hsu, Meen-Hsin Tsai, Sung‐Liang Yu, Kang‐Yi Su, Jeremy J.W. Chen, Gee‐Chen Chang

    Publicado em 2014
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target

    Surface α-Enolase Promotes Extracellular Matrix Degradation and Tumor Metastasis and Represents a New Therapeutic Target por Kuan-Chung Hsiao, Neng-Yao Shih, Hsun-Lang Fang, Tze‐Sing Huang, Ching-Chuan Kuo, Pei‐Yi Chu, Yi‐Mei Hung, Shao-Wen Chou, Yi-Yuan Yang, Gee‐Chen Chang, Ko-Jiunn Liu

    Publicado em 2013
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program

    Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program por Solange Peters, Alessandra Curioni‐Fontecedro, Hovav Nechushtan, Jin‐Yuan Shih, Wei‐Yu Liao, Oliver Gautschi, Vito Spataro, Mojca Unk, James Chih‐Hsin Yang, Robert M. Lorence, Philippe Carrière, A. Cseh, Gee‐Chen Chang

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients with EGFR T790M-Positive NSCLC

    MA02.03 ASTRIS: A Real World Treatment Study of Osimertinib in Patients with EGFR T790M-Positive NSCLC por Yi‐Long Wu, Byoung Chul Cho, Qing Zhou, Gee‐Chen Chang, Liyan Jiang, Giulio Metro, Claudio Martín, Gilberto de Castro, Johan Vansteenkiste, David Vicente, A. Milner, James R. Rigas, Y. Chen, Mariano Provencio

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Pretreatment Epidermal Growth Factor Receptor (<i>EGFR</i>) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Cancer

    Pretreatment Epidermal Growth Factor Receptor (<i>EGFR</i>) T790M Mutation Predicts Shorter EGFR Tyrosine Kinase Inhibitor Response Duration in Patients With Non–Small-Cell Lung Ca... por Kang‐Yi Su, Hsuan‐Yu Chen, Ker-Chau Li, Min‐Liang Kuo, James Chih‐Hsin Yang, Wing‐Kai Chan, Bing‐Ching Ho, Gee‐Chen Chang, Jin‐Yuan Shih, Sung‐Liang Yu, Pan‐Chyr Yang

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    HOXA5 Inhibits Metastasis via Regulating Cytoskeletal Remodelling and Associates with Prolonged Survival in Non-Small-Cell Lung Carcinoma

    HOXA5 Inhibits Metastasis via Regulating Cytoskeletal Remodelling and Associates with Prolonged Survival in Non-Small-Cell Lung Carcinoma por Chi-Chung Wang, Kang‐Yi Su, Hsuan‐Yu Chen, So-Yi Chang, Chi-Fan Shen, Chia-Hung Hsieh, Qi-Sheng Hong, Ching-Cheng Chiang, Gee‐Chen Chang, Sung‐Liang Yu, Jeremy J.W. Chen

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  18. 18
    The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarcinoma

    The Association of Acquired T790M Mutation with Clinical Characteristics after Resistance to First-Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Lung Adenocarc... por Yen-Hsiang Huang, Kuo-Hsuan Hsu, Jeng‐Sen Tseng, Kun‐Chieh Chen, Chia-Hung Hsu, Kang‐Yi Su, Jeremy J.W. Chen, Huei‐Wen Chen, Sung‐Liang Yu, Tsung‐Ying Yang, Gee‐Chen Chang

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report

    Osimertinib Plus Durvalumab versus Osimertinib Monotherapy in EGFR T790M–Positive NSCLC following Previous EGFR TKI Therapy: CAURAL Brief Report por James Chih‐Hsin Yang, Frances A. Shepherd, Dong‐Wan Kim, Gyeong‐Won Lee, Jong Seok Lee, Gee‐Chen Chang, Sung Sook Lee, Yu‐Feng Wei, Yun Gyoo Lee, Gianluca Laus, Barbara Collins, Francesca Pisetzky, Leora Horn

    Publicado em 2019
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis

    Hypoxia-induced Slug SUMOylation enhances lung cancer metastasis por Pei-Fang Hung, Tse‐Ming Hong, Che‐Chang Chang, Chung‐Lieh Hung, Yuan-Ling Hsu, Yih‐Leong Chang, Chen‐Tu Wu, Gee‐Chen Chang, Nei‐Li Chan, Sung‐Liang Yu, Pan‐Chyr Yang, Szu‐Hua Pan

    Publicado em 2019
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: